These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2607410)
21. [Microcapsules with modulable properties made with cross-linked proteins and polysaccharides]. Lévy MC; Andry MC Therapie; 1989; 44(5):365-9. PubMed ID: 2814915 [TBL] [Abstract][Full Text] [Related]
22. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994 [TBL] [Abstract][Full Text] [Related]
23. Reservoir-type microcapsules prepared by the solvent exchange method: effect of formulation parameters on microencapsulation of lysozyme. Park JH; Ye M; Yeo Y; Lee WK; Paul C; Park K Mol Pharm; 2006; 3(2):135-43. PubMed ID: 16579642 [TBL] [Abstract][Full Text] [Related]
24. Glucose-sensitive microcapsules from glutaraldehyde cross-linked hemoglobin and glucose oxidase. Qi W; Yan X; Duan L; Cui Y; Yang Y; Li J Biomacromolecules; 2009 May; 10(5):1212-6. PubMed ID: 19323511 [TBL] [Abstract][Full Text] [Related]
25. Formation and size tuning of colloidal microcapsules via host-guest molecular recognition at the liquid-liquid interface. Patra D; Ozdemir F; Miranda OR; Samanta B; Sanyal A; Rotello VM Langmuir; 2009 Dec; 25(24):13852-4. PubMed ID: 19537702 [TBL] [Abstract][Full Text] [Related]
26. The effect of the chemical composition of albumin-containing microcapsules upon their properties. Dolinska B; Ryszka F Boll Chim Farm; 2003; 142(6):244-7. PubMed ID: 14606263 [TBL] [Abstract][Full Text] [Related]
27. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218 [TBL] [Abstract][Full Text] [Related]
28. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380 [TBL] [Abstract][Full Text] [Related]
29. Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers. Dusseault J; Leblond FA; Robitaille R; Jourdan G; Tessier J; Ménard M; Henley N; Hallé JP Biomaterials; 2005 May; 26(13):1515-22. PubMed ID: 15522753 [TBL] [Abstract][Full Text] [Related]
30. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Erickson LC; Ramonas LM; Zaharko DS; Kohn KW Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062 [TBL] [Abstract][Full Text] [Related]
31. Fourier-transform infrared spectroscopic studies of cross-linked human serum albumin microcapsules. 2. Influence of reaction time on spectra and correlation with microcapsule morphology and size. Levy MC; Lefebvre S; Andry MC; Rahmouni M; Manfait M J Pharm Sci; 1994 Mar; 83(3):419-22. PubMed ID: 8207694 [TBL] [Abstract][Full Text] [Related]
32. Novel alginate-poly(L-histidine) microcapsules as drug carriers: in vitro protein release and short term stability. Wang SB; Xu FH; He HS; Weng LJ Macromol Biosci; 2005 May; 5(5):408-14. PubMed ID: 15889387 [TBL] [Abstract][Full Text] [Related]
33. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics. Koch S; Schwinger C; Kressler J; Heinzen Ch; Rainov NG J Microencapsul; 2003; 20(3):303-16. PubMed ID: 12881112 [TBL] [Abstract][Full Text] [Related]
34. Melting and swelling behaviors of UV-irradiated gelatin gel microcapsules. Yamamoto T; Koike M; Dobashi T Langmuir; 2007 Jul; 23(16):8531-7. PubMed ID: 17616156 [TBL] [Abstract][Full Text] [Related]
36. Effect of particle size on the in vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsules. Visscher GE; Pearson JE; Fong JW; Argentieri GJ; Robison RL; Maulding HV J Biomed Mater Res; 1988 Aug; 22(8):733-46. PubMed ID: 3215907 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and characterisation of aqueous haemoglobin-based microcapsules coated by genipin-cross-linked albumin. Schakowski KM; Linders J; Ferenz KB; Kirsch M J Microencapsul; 2020 May; 37(3):193-204. PubMed ID: 31950867 [TBL] [Abstract][Full Text] [Related]
38. Biodegradable cross-linked starch/protein microcapsules containing proteinase inhibitor for oral protein administration. Larionova NV; Ponchel G; Duchêne D; Larionova NI Int J Pharm; 1999 Nov; 189(2):171-8. PubMed ID: 10536245 [TBL] [Abstract][Full Text] [Related]
39. Biocompatibility of subsieve-size capsules versus conventional-size microcapsules. Sakai S; Mu C; Kawabata K; Hashimoto I; Kawakami K J Biomed Mater Res A; 2006 Aug; 78(2):394-8. PubMed ID: 16680700 [TBL] [Abstract][Full Text] [Related]